Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncology Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Loxo Oncology drug RETEVMO appeared first on DrugPatentWat…
Annual Drug Patent Expirations for TAZVERIK Tazverik is a drug marketed by Epizyme Inc and is included in one NDA. There are twenty patents protecting this drug. This drug has…
The post New patent for Epizyme Inc drug TAZVERIK appeared first on DrugPat…
Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent for Eli Lilly drug OLUMIANT appeared first on DrugPatentWatch – Ma…
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are thirty-six patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appear…
Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Bristol Myers drug SPRYCEL appeared first on…
New patent expiration for Bristol Myers drug SPRYCEL Read Post »
Annual Drug Patent Expirations for CAMPTOSAR Camptosar is a drug marketed by Pfizer Inc and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Pfizer Inc drug CAMPTOSAR appeared first on…
New patent expiration for Pfizer Inc drug CAMPTOSAR Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Spain? Read Post »
Annual Drug Patent Expirations for BYFAVO Byfavo is a drug marketed by Acacia and is included in one NDA. The generic ingredient in BYFAVO is remimazolam besylate. Additional details are…
The post New patent for Acacia drug BYFAVO appeared first on Dru…
Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Sunovion Resp drug LONHALA MAGN…
New patent expiration for Sunovion Resp drug LONHALA MAGNAIR KIT Read Post »
Annual Drug Patent Expirations for METADATE+CD Metadate Cd is a drug marketed by Lannett Co Inc and is included in one NDA. It is available from one supplier. There is…
The post New patent expiration for Lannett Co drug METADATE CD appeared first on Dr…
New patent expiration for Lannett Co drug METADATE CD Read Post »
Get new actionable insights and updates from BiotechBlog
